Mechanical circulatory support: State of the art and future perspectives

Perfusion

Volumn 18, Issue 4, 2003, Pages 233-243

  Wheeldon, Dereck R ^a,b  

^a World Heart Corporation   (Canada)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA BALLOON; ARTICLE; ARTIFICIAL HEART; ASSISTED CIRCULATION; BLOOD PUMP; COST BENEFIT ANALYSIS; COST OF ILLNESS; ELECTIVE SURGERY; EQUIPMENT DESIGN; FEASIBILITY STUDY; HEALTH CARE COST; HEALTH CARE PLANNING; HEART ASSIST DEVICE; HEART FAILURE; HOSPITAL PERSONNEL; HUMAN; INFUSION PUMP; INTENSIVE CARE UNIT; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PATIENT CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PUMP DESIGN;

EQUIPMENT DESIGN; HEART-ASSIST DEVICES; HUMANS;

EID: 0141959311     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659103pf674oa     Document Type: Article

References (26)

1. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994; 3: S107.
2. Park MH, Pathak H, Starling RC et al. Failure to wean from parenteral inotropes: a strong predictor for early mortality among patients with end stage heart disease. J Heart Lung Transplant 1999; 18: 47 (abstract).
3. Cowie MR, Wood DA, Coats AJ et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999; 20: 421-28.
4. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: seventeenth official report - 2000. J Heart Lung Transplant 2000; 19: 909-31.
5. Evans RW. Cardiac replacement: estimation of need, demand and supply. In Rose EA, Stevenson LW eds. Management of end-stage heart disease. Philadelphia, PA: Lippencott-Raven, 1998; 13-24.
6. Rose EA, Moskowitz AJ, Packer M et al. The REMATCH trial: rationale, design and end points. Ann Thorac Surg 1999; 67: 723-30.
7. Portner PM. Permanent mechanical circulatory assistance. In Baumgartner WA, Reitz B, Kasper E, Theodore J eds. Heart and lung transplantation, second edition. Philadelphia, PA: WB Saunders Co., 2002: 531-57.
8. Naftel DC, Brown RN. Survival after heart transplantation. In Kirklin JK, Young JB, McGiffin DC eds. Heart transplantation. Philadelphia, PA: Churchill Livingstone, 2002: 587-614.
9. Wheeldon DR, LaForge DH, Lee L, Jansen PGM, Jassawalla JS, Portner PM. Novacor left ventricular assist system long-term performance: comparison of clinical experience with demonstrated in vitro reliability. ASAIO J 2002; 48: 546-51.
10. Goldstein DJ. Thermo cardiosystems ventricular assist devices. In Goldstein DJ, Oz MC eds. Cardiac assist devices. New York: Futura Publishing Co., 2000: 307-39.
11. Mehta SM, Pae WE, Rosenberg G. The LionHeart LVD-2000: a completely implanted LVAD for chronic circulatory support. Ann Thorac Surg 2001; 71: S156.
12. Reul HM, Akdis M. Blood pumps for circulatory support. Perfusion 2000; 15: 295-311.
13. DeBakey ME. A miniature implantable axial flow ventricular assist device. Ann Thorac Surg 1999; 68: 637-40.
14. Holman WL, Kormos RL. Mechanical support of the failing heart. In Kirklin JK, Young JB, McGiffin DC eds. Heart transplantation. Philadelphia, PA: Churchill Livingstone, 2002: 252-89.
15. Butler KC, Dow JJ, Litwak P. Development of the Nimbus/Pittsburgh axial flow left ventricular assist system. Artif Organs 1997; 21: 602-10.
16. INCOR at www.berlinheart.de
17. Copeland JG, Arabia FA, Banchy ME et al. The CardioWest total artificial heart bridge to transplantation: 1993 to 1996 national trial. Ann Thorac Surg 1998; 66: 1662-69.
18. Kung RTV. Total artificial heart. In Rose EA, Stevenson LW eds. Management of end-stage heart disease. Philadelphia, PA: Lippincott-Raven, 1998: 213-20.
19. Pae WE, Miller CA, Mathews Y, Pierce WS. Ventricular assist devices for postcardiotomy cardiogenic shock: a combined registry experience. J Thorac Cardiovasc Surg 1992; 104: 541-52.
20. Aaronson KD, Eppinger MJ, Dyke DB, Wright S, Pagani FD. Left ventricular assist device therapy improves utilisation of donor hearts. J Am Coll Cardiol 2002; 39: 1247-54.
21. Yacoub MH, Birks EJ, Tansley P, Henien MY, Bowles CT. Bridge to recovery: the Harefield approach. J Cong Heart Failure Circ Supp 2001; 2: 27-30.
22. Artrip JH, Burkhoff D. Epicardial compression mechanical devices. In Goldstein DJ, Oz MC eds. Cardiac assist devices. New York: Futura Publishing Co., 2000: 387-402.
23. Thoratec provides update on Destination Therapy cost data. www.thoratec.com/PubNewsStory
24. Benatar D, Bondmass M, Ghitelman J, Avitall B. Outcomes of chronic heart failure. Arch Intern Med 2003; 163: 347-52.
25. Moskowitz A, Williams DL, Tierney A, Levitan RG, Zivin J, Gelijns AC. Economic considerations of left ventricular assist device implantation. In Goldstein DJ, Oz MC eds. Cardiac assist devices. New York: Futura Publishing Co., 2000: 183-92.
26. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Poirier V. Multicenter clinical evaluation of Heart-Mate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001; 122: 1186-95.